StockDriftsStockDriftsTop 3 Northpond Ventures, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KYTX | KYVERNA THERAPEUTICS INC | 36.46% | 3.26M | $15.9M | +0.00%(+0) | — | 2024-09-30 | |
| VIGL | VIGIL NEUROSCIENCE INC | 32.82% | 4.21M | $14.3M | +0.00%(+0) | — | 2024-09-30 | |
| CADL | CANDEL THERAPEUTICS INC | 30.72% | 1.94M | $13.4M | +0.00%(+0) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Northpond Ventures, Llc reports $43.66M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are KYTX (36.5%), VIGL (32.8%) and CADL (30.7%). Figures reflect the Q3 2024 filing.
Sign up free to track Northpond Ventures, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Northpond Ventures, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1911245). View Northpond Ventures, Llc’s 13F filings on SEC